Frank Camma analyst

Currently out of the existing stock ratings of Frank Camma, 20 are a BUY (48.78%), 21 are a HOLD (51.22%).

Frank Camma

Work Performance Price Targets & Ratings Chart

Analyst Frank Camma, carries an average stock price target met ratio of 73.61% that have a potential upside of 42.61% achieved within 662 days. Previously, Frank Camma worked at SIDOTI.

Frank Camma’s has documented 79 price targets and ratings displayed on 13 stocks. The coverage was on Consumer Defensive, Consumer Cyclical, Industrials, Healthcare sectors.

Most recent stock forecast was given on PBH, Prestige Brand Holdings at 24-Sep-2025.

Wall Street Analyst Frank Camma

Analyst best performing recommendations are on MED (MEDIFAST INC).
The best stock recommendation documented was for TREX (TREX COMPANY) at 8/6/2019. The price target of $42 was fulfilled within 7 days with a profit of $1.5 (3.7%) receiving and performance score of 5.29.

Average potential price target upside

HELE Helen of Troy Ltd IRBT iRobot MED MEDIFAST INC TREX Trex Company WTW Willis Towers Watson PLC MOV Movado Group WW WW International CENTA Central Garden & Pet Company A LCUT Lifetime Brands LANC Lancaster Colony RICK RCI Hospitality Holdings IR Ingersoll Rand PBH Prestige Brand Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 07-Oct-2025

$25

$-3.63 (-12.68%)

$23

2 months 20 days ago
(09-Jul-2026)

8/17 (47.06%)

$-2.43 (-8.86%)

97

Hold Since 17-Apr-2023

$28

$-0.63 (-2.20%)

$25

2 months 20 days ago
(09-Jul-2026)

14/21 (66.67%)

$0.57 (2.08%)

72

Hold Since 10-Oct-2024

$78

$49.62 (174.84%)

$71

1 years 10 months 4 days ago
(25-Nov-2024)

26/36 (72.22%)

$6.33 (8.83%)

127

Hold Since 12-Jul-2022

$235

4 years 2 months 17 days ago
(12-Jul-2022)

5/5 (100%)

$20.9 (9.76%)

70

Buy Since 12-Sep-2017

$206

$177.37 (619.52%)

$206

4 years 2 months 22 days ago
(07-Jul-2022)

3/5 (60%)

$51.25 (33.12%)

132

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?